Extracted from this filing and checked against the source text.
Shareholder VotesSEC 8-K Item 5.07confidence 0.9
Nuvation Bio Inc. shareholders approved Advisory vote on executive compensation at the 2023-05-15 meeting.
Proposal
say on pay
Outcome
passed
Meeting
2023-05-15
Exact text from the filing
Proposal No. 3 – To approve, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement. The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement. FOR AGAINST ABSTAIN BROKER NON-VOTE 153,714,329 38,025,124 9,887 14,982,485
Nuvation Bio Inc. shareholders approved Ratification of Independent Registered Public Accounting Firm at the 2023-05-15 meeting.
Proposal
auditor ratification
Outcome
passed
Meeting
2023-05-15
Exact text from the filing
The Company’s stockholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. FOR AGAINST ABSTAIN BROKER NON-VOTE 206,334,068 118,931 278,826 0
Nuvation Bio Inc. shareholders approved Election of Directors at the 2023-05-15 meeting.
Proposal
director election
Outcome
passed
Meeting
2023-05-15
Exact text from the filing
The individuals listed below were elected at the Annual Meeting to serve as directors of the Company until the Company’s 2026 annual meeting of stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal. CLASS A STOCK DIRECTORS: FOR WITHHELD BROKER NON-VOTE Mr. Robert B. Bazemore, Jr. 140,642,378 50,106,962 14,982,485 CLASS B STOCK DIRECTORS: FOR WITHHELD BROKER NON-VOTE Kim Blickenstaff 1,000,000 0 0
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.